VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q43092531 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241221010714.0
008 241221nneanz||abbn n and d
035 ‎‡a (WKP)Q43092531‏
024 ‎‡a 0000-0001-7464-0324‏ ‎‡2 orcid‏
024 ‎‡a 7401466555‏ ‎‡2 scopus‏
035 ‎‡a (OCoLC)Q43092531‏
100 0 ‎‡a Max Bell‏ ‎‡9 ast‏ ‎‡9 es‏ ‎‡9 sl‏
375 ‎‡a 1‏ ‎‡2 iso5218‏
400 0 ‎‡a Max Bell‏ ‎‡c researcher‏ ‎‡9 en‏
400 0 ‎‡a Max Bell‏ ‎‡c wetenschapper‏ ‎‡9 nl‏
670 ‎‡a Author's Acute kidney injury after coronary artery bypass grafting and long-term risk of myocardial infarction and death‏
670 ‎‡a Author's Acute kidney injury following coronary artery bypass grafting: early mortality and postoperative complications‏
670 ‎‡a Author's Acute Kidney Injury: New Concepts, Renal Recovery‏
670 ‎‡a Author's Assessment of cell-cycle arrest biomarkers to predict early and delayed acute kidney injury‏
670 ‎‡a Author's Assessment of plasma endostatin to predict acute kidney injury in critically ill patients‏
670 ‎‡a Author's Association of plasma neutrophil gelatinase-associated lipocalin‏
670 ‎‡a Author's Association of plasma neutrophil gelatinase-associated lipocalin (NGAL) with sepsis and acute kidney dysfunction‏
670 ‎‡a Author's Authors’ Response‏
670 ‎‡a Author's Coeliac disease and risk of sepsis‏
670 ‎‡a Author's Comparison of the Accuracy of the Novel PrisMax Continuous Renal Replacement Therapy System to the Classic Prismaflex System‏
670 ‎‡a Author's Continuous renal replacement therapy in septic patients: is it really harmful?‏
670 ‎‡a Author's Continuous renal replacement therapy is associated with less chronic renal failure than intermittent haemodialysis after acute renal failure‏
670 ‎‡a Author's Cystatin C is correlated with mortality in patients with and without acute kidney injury.‏
670 ‎‡a Author's Cystatin C: More than a renal function marker‏
670 ‎‡a Author's Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury‏
670 ‎‡a Author's Early lumbar puncture in adult bacterial meningitis--rationale for revised guidelines‏
670 ‎‡a Author's End-stage renal disease patients on renal replacement therapy in the intensive care unit: Short- and long-term outcome*‏
670 ‎‡a Author's Evolution of chronic renal impairment and long-term mortality after de novo acute kidney injury in the critically ill; a Swedish multi-centre cohort study‏
670 ‎‡a Author's Findings of the first consensus conference on medical emergency teams‏
670 ‎‡a Author's Hypothermia during CRRT, a comparative analysis‏
670 ‎‡a Author's ICU admittance by a rapid response team versus conventional admittance, characteristics, and outcome‏
670 ‎‡a Author's Immunoassays distinguishing between HNL/NGAL released in urine from kidney epithelial cells and neutrophils‏
670 ‎‡a Author's Impact of sepsis on levels of plasma cystatin C in AKI and non-AKI patients‏
670 ‎‡a Author's Intra-day variability of cystatin C, creatinine and estimated GFR in intensive care patients‏
670 ‎‡a Author's Intraoperative hypotension is associated with myocardial damage in noncardiac surgery: An observational study‏
670 ‎‡a Author's LiFe: a liver injury score to predict outcome in critically ill patients‏
670 ‎‡a Author's Limitations of medical treatment among patients attended by the rapid response team‏
670 ‎‡a Author's Long-term mortality and risk factors for development of end-stage renal disease in critically ill patients with and without chronic kidney disease‏
670 ‎‡a Author's Long-term outcome after acute renal replacement therapy: a narrative review‏
670 ‎‡a Author's Long-term outcome after intensive care: can we protect the kidney?‏
670 ‎‡a Author's National Early Warning Score vs Rapid Response Team criteria-Prevalence, misclassification, and outcome‏
670 ‎‡a Author's Neutrophil gelatinase-associated lipocalin in adult septic patients with and without acute kidney injury‏
670 ‎‡a Author's Novel biomarkers of acute kidney injury and failure: clinical applicability‏
670 ‎‡a Author's Optimal follow-up time after continuous renal replacement therapy in actual renal failure patients stratified with the RIFLE criteria‏
670 ‎‡a Author's Pheochromocytoma-Induced Inverted Takotsubo-Like Cardiomyopathy Leading to Cardiogenic Shock Successfully Treated With Extracorporeal Membrane Oxygenation‏
670 ‎‡a Author's Plasma endostatin may improve acute kidney injury risk prediction in critically ill patients‏
670 ‎‡a Author's Prevalence and sensitivity of MET-criteria in a Scandinavian University Hospital‏
670 ‎‡a Author's Quantification of postprandial triglyceride-rich lipoproteins in healthy men by retinyl ester labeling and simultaneous measurement of apolipoproteins B-48 and B-100.‏
670 ‎‡a Author's Reducing in-hospital cardiac arrests and hospital mortality by introducing a medical emergency team‏
670 ‎‡a Author's Renal support in critically ill patients with acute kidney injury.‏
670 ‎‡a Author's Superiority of Serum Cystatin C Over Creatinine in Prediction of Long-Term Prognosis at Discharge From ICU.‏
670 ‎‡a Author's The authors reply‏
670 ‎‡a Author's The deteriorating ward patient: a Swedish-Australian comparison‏
670 ‎‡a Author's The impact of patient sex on intensive care unit admission: a blinded randomized survey‏
670 ‎‡a Author's The influence of gender on ICU admittance‏
670 ‎‡a Author's The Novel PrisMax Continuous Renal Replacement Therapy System in a Multinational, Multicentre Pilot Setting‏
670 ‎‡a Author's Time dependent influence of host factors on outcome after trauma‏
670 ‎‡a Author's Understanding renal recovery.‏
670 ‎‡a Author's 인간 급성 신장 손상에서 세포주기 정지 바이오마커의 발견 및 검증‏
909 ‎‡a (orcid) 0000000174640324‏ ‎‡9 1‏
909 ‎‡a (scopus) 7401466555‏ ‎‡9 1‏
912 ‎‡a authorsreply‏ ‎‡A The authors reply‏ ‎‡9 1‏
912 ‎‡a authorsresponse‏ ‎‡A Authors’ Response‏ ‎‡9 1‏
919 ‎‡a neutrophilgelatinaseassociatedlipocalininadultsepticpatientswithandwithoutacutekidneyinjury‏ ‎‡A Neutrophil gelatinase-associated lipocalin in adult septic patients with and without acute kidney injury‏ ‎‡9 1‏
919 ‎‡a optimalfollowuptimeaftercontinuousrenalreplacementtherapyinactualrenalfailurepatientsstratifiedwiththeriflecriteria‏ ‎‡A Optimal follow-up time after continuous renal replacement therapy in actual renal failure patients stratified with the RIFLE criteria‏ ‎‡9 1‏
919 ‎‡a pheochromocytomainducedinvertedtakotsubolikecardiomyopathyleadingtocardiogenicshocksuccessfullytreatedwithextracorporealmembraneoxygenation‏ ‎‡A Pheochromocytoma-Induced Inverted Takotsubo-Like Cardiomyopathy Leading to Cardiogenic Shock Successfully Treated With Extracorporeal Membrane Oxygenation‏ ‎‡9 1‏
919 ‎‡a plasmaendostatinmayimproveacutekidneyinjuryriskpredictionincriticallyillpatients‏ ‎‡A Plasma endostatin may improve acute kidney injury risk prediction in critically ill patients‏ ‎‡9 1‏
919 ‎‡a prevalenceandsensitivityofmetcriteriainascandinavianuniversityhospital‏ ‎‡A Prevalence and sensitivity of MET-criteria in a Scandinavian University Hospital‏ ‎‡9 1‏
919 ‎‡a quantificationofpostprandialtriglyceriderichlipoproteinsinhealthymenbyretinylesterlabelingandsimultaneousmeasurementofapolipoproteinsb48andb100‏ ‎‡A Quantification of postprandial triglyceride-rich lipoproteins in healthy men by retinyl ester labeling and simultaneous measurement of apolipoproteins B-48 and B-100.‏ ‎‡9 1‏
919 ‎‡a reducinginhospitalcardiacarrestsandhospitalmortalitybyintroducingamedicalemergencyteam‏ ‎‡A Reducing in-hospital cardiac arrests and hospital mortality by introducing a medical emergency team‏ ‎‡9 1‏
919 ‎‡a renalsupportincriticallyillpatientswithacutekidneyinjury‏ ‎‡A Renal support in critically ill patients with acute kidney injury.‏ ‎‡9 1‏
919 ‎‡a superiorityofserumcystatin100overcreatinineinpredictionoflongtermprognosisatdischargefromicu‏ ‎‡A Superiority of Serum Cystatin C Over Creatinine in Prediction of Long-Term Prognosis at Discharge From ICU.‏ ‎‡9 1‏
919 ‎‡a deterioratingwardpatientaswedishaustraliancomparison‏ ‎‡A The deteriorating ward patient: a Swedish-Australian comparison‏ ‎‡9 1‏
919 ‎‡a impactofpatientsexonintensivecareunitadmissionablindedrandomizedsurvey‏ ‎‡A The impact of patient sex on intensive care unit admission: a blinded randomized survey‏ ‎‡9 1‏
919 ‎‡a influenceofgenderonicuadmittance‏ ‎‡A The influence of gender on ICU admittance‏ ‎‡9 1‏
919 ‎‡a novelprismaxcontinuousrenalreplacementtherapysysteminamultinationalmulticentrepilotsetting‏ ‎‡A The Novel PrisMax Continuous Renal Replacement Therapy System in a Multinational, Multicentre Pilot Setting‏ ‎‡9 1‏
919 ‎‡a timedependentinfluenceofhostfactorsonoutcomeaftertrauma‏ ‎‡A Time dependent influence of host factors on outcome after trauma‏ ‎‡9 1‏
919 ‎‡a understandingrenalrecovery‏ ‎‡A Understanding renal recovery.‏ ‎‡9 1‏
919 ‎‡a 인간급성신장손상에서세포주기정지바이오마커의발견및검증‏ ‎‡A 인간 급성 신장 손상에서 세포주기 정지 바이오마커의 발견 및 검증‏ ‎‡9 1‏
919 ‎‡a novelbiomarkersofacutekidneyinjuryandfailureclinicalapplicability‏ ‎‡A Novel biomarkers of acute kidney injury and failure: clinical applicability‏ ‎‡9 1‏
919 ‎‡a acutekidneyinjuryaftercoronaryarterybypassgraftingandlongtermriskofmyocardialinfarctionanddeath‏ ‎‡A Acute kidney injury after coronary artery bypass grafting and long-term risk of myocardial infarction and death‏ ‎‡9 1‏
919 ‎‡a acutekidneyinjuryfollowingcoronaryarterybypassgraftingearlymortalityandpostoperativecomplications‏ ‎‡A Acute kidney injury following coronary artery bypass grafting: early mortality and postoperative complications‏ ‎‡9 1‏
919 ‎‡a acutekidneyinjurynewconceptsrenalrecovery‏ ‎‡A Acute Kidney Injury: New Concepts, Renal Recovery‏ ‎‡9 1‏
919 ‎‡a assessmentofcellcyclearrestbiomarkerstopredictearlyanddelayedacutekidneyinjury‏ ‎‡A Assessment of cell-cycle arrest biomarkers to predict early and delayed acute kidney injury‏ ‎‡9 1‏
919 ‎‡a assessmentofplasmaendostatintopredictacutekidneyinjuryincriticallyillpatients‏ ‎‡A Assessment of plasma endostatin to predict acute kidney injury in critically ill patients‏ ‎‡9 1‏
919 ‎‡a associationofplasmaneutrophilgelatinaseassociatedlipocalin‏ ‎‡A Association of plasma neutrophil gelatinase-associated lipocalin‏ ‎‡9 1‏
919 ‎‡a associationofplasmaneutrophilgelatinaseassociatedlipocalinngalwithsepsisandacutekidneydysfunction‏ ‎‡A Association of plasma neutrophil gelatinase-associated lipocalin (NGAL) with sepsis and acute kidney dysfunction‏ ‎‡9 1‏
919 ‎‡a coeliacdiseaseandriskofsepsis‏ ‎‡A Coeliac disease and risk of sepsis‏ ‎‡9 1‏
919 ‎‡a comparisonoftheaccuracyofthenovelprismaxcontinuousrenalreplacementtherapysystemtotheclassicprismaflexsystem‏ ‎‡A Comparison of the Accuracy of the Novel PrisMax Continuous Renal Replacement Therapy System to the Classic Prismaflex System‏ ‎‡9 1‏
919 ‎‡a continuousrenalreplacementtherapyinsepticpatientsisitreallyharmful‏ ‎‡A Continuous renal replacement therapy in septic patients: is it really harmful?‏ ‎‡9 1‏
919 ‎‡a continuousrenalreplacementtherapyisassociatedwithlesschronicrenalfailurethanintermittenthaemodialysisafteracuterenalfailure‏ ‎‡A Continuous renal replacement therapy is associated with less chronic renal failure than intermittent haemodialysis after acute renal failure‏ ‎‡9 1‏
919 ‎‡a cystatin100iscorrelatedwithmortalityinpatientswithandwithoutacutekidneyinjury‏ ‎‡A Cystatin C is correlated with mortality in patients with and without acute kidney injury.‏ ‎‡9 1‏
919 ‎‡a cystatin100morethanarenalfunctionmarker‏ ‎‡A Cystatin C: More than a renal function marker‏ ‎‡9 1‏
919 ‎‡a discoveryandvalidationofcellcyclearrestbiomarkersinhumanacutekidneyinjury‏ ‎‡A Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury‏ ‎‡9 1‏
919 ‎‡a earlylumbarpunctureinadultbacterialmeningitisrationaleforrevisedguidelines‏ ‎‡A Early lumbar puncture in adult bacterial meningitis--rationale for revised guidelines‏ ‎‡9 1‏
919 ‎‡a endstagerenaldiseasepatientsonrenalreplacementtherapyintheintensivecareunitshortandlongtermoutcome‏ ‎‡A End-stage renal disease patients on renal replacement therapy in the intensive care unit: Short- and long-term outcome*‏ ‎‡9 1‏
919 ‎‡a evolutionofchronicrenalimpairmentandlongtermmortalityafterdenovoacutekidneyinjuryinthecriticallyillaswedishmulticentrecohortstudy‏ ‎‡A Evolution of chronic renal impairment and long-term mortality after de novo acute kidney injury in the critically ill; a Swedish multi-centre cohort study‏ ‎‡9 1‏
919 ‎‡a findingsofthe1consensusconferenceonmedicalemergencyteams‏ ‎‡A Findings of the first consensus conference on medical emergency teams‏ ‎‡9 1‏
919 ‎‡a hypothermiaduringcrrtacomparativeanalysis‏ ‎‡A Hypothermia during CRRT, a comparative analysis‏ ‎‡9 1‏
919 ‎‡a icuadmittancebyarapidresponseteamversusconventionaladmittancecharacteristicsandoutcome‏ ‎‡A ICU admittance by a rapid response team versus conventional admittance, characteristics, and outcome‏ ‎‡9 1‏
919 ‎‡a immunoassaysdistinguishingbetweenhnlngalreleasedinurinefromkidneyepithelialcellsandneutrophils‏ ‎‡A Immunoassays distinguishing between HNL/NGAL released in urine from kidney epithelial cells and neutrophils‏ ‎‡9 1‏
919 ‎‡a impactofsepsisonlevelsofplasmacystatin100inakiandnonakipatients‏ ‎‡A Impact of sepsis on levels of plasma cystatin C in AKI and non-AKI patients‏ ‎‡9 1‏
919 ‎‡a intradayvariabilityofcystatin100creatinineandestimatedgfrinintensivecarepatients‏ ‎‡A Intra-day variability of cystatin C, creatinine and estimated GFR in intensive care patients‏ ‎‡9 1‏
919 ‎‡a intraoperativehypotensionisassociatedwithmyocardialdamageinnoncardiacsurgeryanobservationalstudy‏ ‎‡A Intraoperative hypotension is associated with myocardial damage in noncardiac surgery: An observational study‏ ‎‡9 1‏
919 ‎‡a lifealiverinjuryscoretopredictoutcomeincriticallyillpatients‏ ‎‡A LiFe: a liver injury score to predict outcome in critically ill patients‏ ‎‡9 1‏
919 ‎‡a limitationsofmedicaltreatmentamongpatientsattendedbytherapidresponseteam‏ ‎‡A Limitations of medical treatment among patients attended by the rapid response team‏ ‎‡9 1‏
919 ‎‡a longtermmortalityandriskfactorsfordevelopmentofendstagerenaldiseaseincriticallyillpatientswithandwithoutchronickidneydisease‏ ‎‡A Long-term mortality and risk factors for development of end-stage renal disease in critically ill patients with and without chronic kidney disease‏ ‎‡9 1‏
919 ‎‡a longtermoutcomeafteracuterenalreplacementtherapyanarrativereview‏ ‎‡A Long-term outcome after acute renal replacement therapy: a narrative review‏ ‎‡9 1‏
919 ‎‡a longtermoutcomeafterintensivecarecanweprotectthekidney‏ ‎‡A Long-term outcome after intensive care: can we protect the kidney?‏ ‎‡9 1‏
919 ‎‡a nationalearlywarningscorevsrapidresponseteamcriteriaprevalencemisclassificationandoutcome‏ ‎‡A National Early Warning Score vs Rapid Response Team criteria-Prevalence, misclassification, and outcome‏ ‎‡9 1‏
946 ‎‡a b‏ ‎‡9 1‏
996 ‎‡2 LC|nb2022017823‏
996 ‎‡2 CAOONL|ncf11180553‏
996 ‎‡2 ISNI|0000000063275221‏
996 ‎‡2 SELIBR|316122‏
996 ‎‡2 BIBSYS|6065110‏
996 ‎‡2 DNB|1115213318‏
996 ‎‡2 DNB|1220326623‏
996 ‎‡2 BAV|495_336290‏
996 ‎‡2 LC|n 92805763‏
996 ‎‡2 J9U|987007435036405171‏
996 ‎‡2 LC|n 97105749‏
996 ‎‡2 LC|n 2010011689‏
996 ‎‡2 NLA|000035385498‏
996 ‎‡2 BNE|XX1069148‏
996 ‎‡2 NUKAT|n 2004080953‏
996 ‎‡2 LC|nr 96036572‏
996 ‎‡2 CAOONL|ncf11203197‏
996 ‎‡2 J9U|987007459648005171‏
996 ‎‡2 RERO|A005626160‏
996 ‎‡2 DNB|1148476598‏
996 ‎‡2 NUKAT|n 2006098811‏
996 ‎‡2 ISNI|0000000067199801‏
996 ‎‡2 DNB|1022551124‏
996 ‎‡2 RERO|A006170277‏
996 ‎‡2 ISNI|0000000077516954‏
996 ‎‡2 NTA|068995814‏
996 ‎‡2 DNB|115537651‏
996 ‎‡2 SUDOC|127644903‏
996 ‎‡2 ISNI|0000000064027588‏
996 ‎‡2 ISNI|0000000109872698‏
996 ‎‡2 NII|DA03222858‏
996 ‎‡2 BIBSYS|5019063‏
996 ‎‡2 ISNI|0000000051745580‏
996 ‎‡2 NUKAT|n 2016195242‏
996 ‎‡2 LC|nr 89015967‏
996 ‎‡2 NUKAT|n 2013120322‏
996 ‎‡2 SUDOC|087767007‏
996 ‎‡2 NLA|000036348577‏
996 ‎‡2 NII|DA12806678‏
996 ‎‡2 LC|no2014133397‏
996 ‎‡2 LC|no2007068052‏
996 ‎‡2 DNB|130084654‏
996 ‎‡2 PTBNP|1584395‏
996 ‎‡2 LC|n 87903828‏
996 ‎‡2 ISNI|0000000074881331‏
996 ‎‡2 BNF|12327502‏
996 ‎‡2 J9U|987007345936305171‏
996 ‎‡2 NKC|mzk2013761335‏
996 ‎‡2 DNB|17051773X‏
996 ‎‡2 LC|n 2008024372‏
996 ‎‡2 BNE|XX5112976‏
996 ‎‡2 SUDOC|086231618‏
996 ‎‡2 LC|n 2020049895‏
996 ‎‡2 CAOONL|ncf11192838‏
996 ‎‡2 SELIBR|309311‏
996 ‎‡2 DNB|128443065‏
996 ‎‡2 NII|DA02696085‏
996 ‎‡2 BAV|495_348887‏
996 ‎‡2 LC|no 00096910‏
996 ‎‡2 LC|no2016026502‏
996 ‎‡2 ISNI|0000000036555842‏
996 ‎‡2 ISNI|0000000036453192‏
996 ‎‡2 ISNI|0000000021437640‏
996 ‎‡2 BIBSYS|90339579‏
996 ‎‡2 LNB|LNC10-000193025‏
996 ‎‡2 NYNYRILM|218767‏
996 ‎‡2 RERO|A027155662‏
996 ‎‡2 DBC|87097969382401‏
996 ‎‡2 ISNI|0000000078546661‏
996 ‎‡2 NUKAT|n 2011148525‏
996 ‎‡2 BNF|14832973‏
996 ‎‡2 LC|n 83003317‏
996 ‎‡2 CAOONL|ncf10132494‏
996 ‎‡2 BNF|16342525‏
996 ‎‡2 LIH|LNB:V-45757;=BO‏
996 ‎‡2 W2Z|90223816‏
996 ‎‡2 NKC|kup19960000006211‏
996 ‎‡2 SUDOC|144799898‏
996 ‎‡2 SUDOC|127341803‏
996 ‎‡2 BNF|14583495‏
996 ‎‡2 ISNI|0000000396262517‏
996 ‎‡2 LC|no2015085555‏
996 ‎‡2 RERO|A012350558‏
996 ‎‡2 ISNI|0000000078325455‏
996 ‎‡2 LC|nr 99026988‏
996 ‎‡2 J9U|987007375423505171‏
996 ‎‡2 DNB|1070631086‏
996 ‎‡2 LC|no 00093149‏
996 ‎‡2 J9U|987007429917705171‏
996 ‎‡2 NUKAT|n 01028455‏
996 ‎‡2 NSK|000211418‏
996 ‎‡2 ISNI|0000000455131884‏
996 ‎‡2 ISNI|0000000124442856‏
996 ‎‡2 ISNI|0000000109153757‏
996 ‎‡2 N6I|vtls000300234‏
996 ‎‡2 ISNI|0000000048923462‏
996 ‎‡2 J9U|987007454897705171‏
996 ‎‡2 BNF|15112177‏
996 ‎‡2 CAOONL|ncf10157631‏
996 ‎‡2 ISNI|0000000437257424‏
996 ‎‡2 CAOONL|ncf11393931‏
996 ‎‡2 DE633|pe30041940‏
996 ‎‡2 NKC|jcu2016912985‏
996 ‎‡2 DNB|1205683666‏
996 ‎‡2 J9U|987007363703305171‏
996 ‎‡2 NUKAT|n 2006071330‏
996 ‎‡2 DNB|1267025921‏
996 ‎‡2 NTA|328864919‏
996 ‎‡2 BNF|12185316‏
996 ‎‡2 JPG|500106342‏
996 ‎‡2 J9U|987007379076205171‏
996 ‎‡2 BNF|12152759‏
996 ‎‡2 SUDOC|162464398‏
996 ‎‡2 LC|n 77003779‏
996 ‎‡2 LC|n 91010452‏
996 ‎‡2 NUKAT|n 97036742‏
996 ‎‡2 DNB|1243597658‏
996 ‎‡2 NTA|165878835‏
996 ‎‡2 SUDOC|030027748‏
996 ‎‡2 CAOONL|ncf10322064‏
996 ‎‡2 DNB|1089518277‏
996 ‎‡2 ISNI|0000000109981181‏
996 ‎‡2 CAOONL|ncf11237944‏
996 ‎‡2 NKC|mub2017952926‏
996 ‎‡2 NUKAT|n 2007012053‏
996 ‎‡2 PLWABN|9810606918405606‏
996 ‎‡2 ISNI|0000000081880660‏
996 ‎‡2 BNF|10556232‏
996 ‎‡2 RERO|A002986969‏
996 ‎‡2 NII|DA07292800‏
996 ‎‡2 ISNI|0000000043691789‏
996 ‎‡2 NLA|000036030443‏
996 ‎‡2 LC|n 87932784‏
996 ‎‡2 NTA|074735705‏
996 ‎‡2 BIBSYS|99016090‏
996 ‎‡2 NTA|132499010‏
996 ‎‡2 NII|DA13395637‏
996 ‎‡2 LC|n 79114967‏
996 ‎‡2 NLA|000035853479‏
996 ‎‡2 BNCHL|10000000000000000061971‏
996 ‎‡2 LC|no2005044423‏
996 ‎‡2 LC|n 85347294‏
996 ‎‡2 BNC|981058508610906706‏
996 ‎‡2 BIBSYS|90223816‏
996 ‎‡2 ISNI|0000000084499136‏
996 ‎‡2 RERO|A002986970‏
996 ‎‡2 DNB|140673520‏
996 ‎‡2 LC|n 78083515‏
996 ‎‡2 RERO|A002986979‏
996 ‎‡2 LC|nb2014017325‏
996 ‎‡2 NUKAT|n 00026718‏
996 ‎‡2 ISNI|0000000110318483‏
996 ‎‡2 ISNI|0000000083293136‏
996 ‎‡2 LIH|LNB:B_t__x_E;=CD‏
996 ‎‡2 ISNI|0000000032910739‏
996 ‎‡2 DNB|129905194‏
996 ‎‡2 J9U|987007344517205171‏
996 ‎‡2 LNB|LNC10-000157206‏
996 ‎‡2 N6I|vtls002613400‏
996 ‎‡2 BNE|XX1173508‏
996 ‎‡2 LC|n 91098225‏
996 ‎‡2 LC|n 87937852‏
996 ‎‡2 NUKAT|n 2009167519‏
996 ‎‡2 BIBSYS|1592544498728‏
996 ‎‡2 BIBSYS|1592544498723‏
996 ‎‡2 BIBSYS|1592544498722‏
996 ‎‡2 NTA|292192231‏
996 ‎‡2 LC|no2016163176‏
996 ‎‡2 ISNI|0000000117824143‏
996 ‎‡2 LC|n 88625392‏
996 ‎‡2 J9U|987007456005305171‏
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏